Zecha, Judith A. E. M.
Raber-Durlacher, Judith E.
Nair, Raj G.
Epstein, Joel B.
Elad, Sharon
Hamblin, Michael R.
Barasch, Andrei
Migliorati, Cesar A.
Milstein, Dan M. J.
Genot, Marie-Thérèse
Lansaat, Liset
van der Brink, Ron
Arnabat-Dominguez, Josep
van der Molen, Lisette
Jacobi, Irene
van Diessen, Judi
de Lange, Jan
Smeele, Ludi E.
Schubert, Mark M.
Bensadoun, René-Jean
Funding for this research was provided by:
NIH Clinical Center (US NIH grant R01AI050875.)
Article History
Received: 2 August 2015
Accepted: 7 March 2016
First Online: 17 March 2016
Compliance with ethical standards
:
: This article is based on a narrative review of existing data and the clinical observations of an international multidisciplinary panel of clinicians and researchers with expertise in the area of supportive care in cancer and/or PBM clinical application and dosimetry. This article is informational in nature. As with all clinical materials, this paper should be used with the clear understanding that continued research and practice could result in new insights and recommendations. The review reflects the collective opinion and as such does not necessarily represent the opinion of any individual author. In no event shall the authors be liable for any decision made or action taken in reliance on the proposed protocols.
: Judith A.E.M. Zecha, Andrei Barasch, Sharon Elad, Steven Sonis, Cesar A. Migliorati, Marie-Thérèse Genot, Dan M.J. Milstein, Liset Lansaat, Irene Jacobi, Judi van Diessen, Jan. de Lange, Ludi E. Smeele and Mark M. Schubert have no disclosures relevant to this work to report.Judith E. Raber-Durlacher, Raj G. Nair, Joel B. Epstein, Ron van der Brink, Josep Arnabat Dominguez, and Rene-Jean Bensadoun have received travel expenses and hotel accommodation for the founding meeting of iGLOB from THOR Photomedicine Ltd., UK. Raj Nair has received an honorarium from THOR, UK. Michael R Hamblin was supported by US NIH grant R01AI050875.